BIOSPYDER TECHNOLOGIES, INC.

BIOSPYDER TECHNOLOGIES, INC. specializes in high-throughput transcriptomic analysis and targeted RNA sequencing services for environmental and life science research. Leveraging its proprietary TEMPO-SEQ and TEMPO-LINC technologies, the company delivers scalable, precision-based gene expression profiling of complex biological samples, including whole-body homogenates and purified RNA lysates, at scales exceeding thousands of samples per project. Their technical expertise centers on single-cell and bulk RNA sequencing, multiplexed transcriptome analysis, and bioinformatic interpretation of environmental chemical impacts on biological systems, with a strong focus on reproducible, high-depth sequencing protocols meeting stringent federal research standards. The contractor maintains a dominant relationship with the Environmental Protection Agency, providing critical transcriptomic support for studies on environmental toxicology, chemical risk assessment, and natural resource impact analysis. Work includes targeted and whole-transcriptome sequencing of tissue samples collected from EPA laboratories, directly informing regulatory science and environmental health policy. Limited engagement with the Department of Veterans Affairs and Cincinnati Acquisition Division suggests niche, project-specific collaborations, primarily in biomedical research domains. BIOSPYDER’s primary focus lies in NAICS 541715 (research and development in physical, engineering, and life sciences) and 541714 (biotechnology research), reflecting its role as a specialized service provider in molecular biology and genomic analysis. The company operates at the intersection of environmental health and molecular diagnostics, positioning itself as a technical partner for agencies requiring high-volume, high-fidelity transcriptomic data to support evidence-based decision-making. As a small business structured as a 2L entity based in Carlsbad, California, BIOSPYDER operates without federal certifications but maintains a focused, mission-driven presence in the federal R&D market. Its geographic location supports collaboration with West Coast research institutions and federal laboratories, reinforcing its niche as a precision genomics service provider for government science programs.